219 related articles for article (PubMed ID: 8646405)
1. Acetyl-11-keto-beta-boswellic acid (AKBA): structure requirements for binding and 5-lipoxygenase inhibitory activity.
Sailer ER; Subramanian LR; Rall B; Hoernlein RF; Ammon HP; Safayhi H
Br J Pharmacol; 1996 Feb; 117(4):615-8. PubMed ID: 8646405
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acid.
Safayhi H; Sailer ER; Ammon HP
Mol Pharmacol; 1995 Jun; 47(6):1212-6. PubMed ID: 7603462
[TBL] [Abstract][Full Text] [Related]
3. Characterization of an acetyl-11-keto-beta-boswellic acid and arachidonate-binding regulatory site of 5-lipoxygenase using photoaffinity labeling.
Sailer ER; Schweizer S; Boden SE; Ammon HP; Safayhi H
Eur J Biochem; 1998 Sep; 256(2):364-8. PubMed ID: 9760176
[TBL] [Abstract][Full Text] [Related]
4. Acetyl-11-keto-beta-boswellic acid induces apoptosis in HL-60 and CCRF-CEM cells and inhibits topoisomerase I.
Hoernlein RF; Orlikowsky T; Zehrer C; Niethammer D; Sailer ER; Simmet T; Dannecker GE; Ammon HP
J Pharmacol Exp Ther; 1999 Feb; 288(2):613-9. PubMed ID: 9918566
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of new analogs of AKBA and evaluation of their anti-inflammatory activities.
Meka B; Ravada SR; Murali Krishna Kumar M; Purna Nagasree K; Golakoti T
Bioorg Med Chem; 2017 Feb; 25(4):1374-1388. PubMed ID: 28110820
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of the nonredox-type non-competitive leukotriene biosynthesis inhibitor acetyl-11-keto-β-boswellic acid.
Sailer ER; Hoernlein RF; Ammon HP; Safayhi H
Phytomedicine; 1996 May; 3(1):73-4. PubMed ID: 23194865
[TBL] [Abstract][Full Text] [Related]
7. 5-Lipoxygenase inhibition by acetyl-11-keto-β-boswellic acid (AKBA) by a novel mechanism.
Safayhi H; Sailer ER; Ammon HP
Phytomedicine; 1996 May; 3(1):71-2. PubMed ID: 23194864
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic action of acetyl-11-keto-beta-boswellic acid (AKBA) on meningioma cells.
Park YS; Lee JH; Bondar J; Harwalkar JA; Safayhi H; Golubic M
Planta Med; 2002 May; 68(5):397-401. PubMed ID: 12058313
[TBL] [Abstract][Full Text] [Related]
9. Workup-dependent formation of 5-lipoxygenase inhibitory boswellic acid analogues.
Schweizer S; von Brocke AF; Boden SE; Bayer E; Ammon HP; Safayhi H
J Nat Prod; 2000 Aug; 63(8):1058-61. PubMed ID: 10978197
[TBL] [Abstract][Full Text] [Related]
10. Acetyl-11-keto-beta-boswellic acid (AKBA) is cytotoxic for meningioma cells and inhibits phosphorylation of the extracellular-signal regulated kinase 1 and 2.
Park YS; Lee JH; Harwalkar JA; Bondar J; Safayhi H; Golubic M
Adv Exp Med Biol; 2002; 507():387-93. PubMed ID: 12664615
[TBL] [Abstract][Full Text] [Related]
11. Acetyl-11-keto-β-boswellic acid prevents testicular torsion/detorsion injury in rats by modulating 5-LOX/LTB4 and p38-MAPK/JNK/Bax/Caspase-3 pathways.
Ahmed MAE; Ahmed AAE; El Morsy EM
Life Sci; 2020 Nov; 260():118472. PubMed ID: 32971106
[TBL] [Abstract][Full Text] [Related]
12. Microbial transformation of acetyl-11-keto-β-boswellic acid and their inhibitory activity on LPS-induced NO production.
Sun Y; Liu D; Xi R; Wang X; Wang Y; Hou J; Zhang B; Wang C; Liu K; Ma X
Bioorg Med Chem Lett; 2013 Mar; 23(5):1338-42. PubMed ID: 23391590
[TBL] [Abstract][Full Text] [Related]
13. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase.
Safayhi H; Mack T; Sabieraj J; Anazodo MI; Subramanian LR; Ammon HP
J Pharmacol Exp Ther; 1992 Jun; 261(3):1143-6. PubMed ID: 1602379
[TBL] [Abstract][Full Text] [Related]
14. Inhibition by boswellic acids of human leukocyte elastase.
Safayhi H; Rall B; Sailer ER; Ammon HP
J Pharmacol Exp Ther; 1997 Apr; 281(1):460-3. PubMed ID: 9103531
[TBL] [Abstract][Full Text] [Related]
15. Structural and mechanistic insights into 5-lipoxygenase inhibition by natural products.
Gilbert NC; Gerstmeier J; Schexnaydre EE; Börner F; Garscha U; Neau DB; Werz O; Newcomer ME
Nat Chem Biol; 2020 Jul; 16(7):783-790. PubMed ID: 32393899
[TBL] [Abstract][Full Text] [Related]
16. 3-Acetoxy group of genuine AKBA (acetyl-11-keto-beta-boswellic acid) is alpha-configurated.
Schweizer S; Eichele K; Ammon HP; Safayhi H
Planta Med; 2000 Dec; 66(8):781-2. PubMed ID: 11199146
[TBL] [Abstract][Full Text] [Related]
17. Co-administration of acetyl-11-keto-beta-boswellic acid, a specific 5-lipoxygenase inhibitor, potentiates the protective effect of COX-2 inhibitors in kainic acid-induced neurotoxicity in mice.
Bishnoi M; Patil CS; Kumar A; Kulkarni SK
Pharmacology; 2007; 79(1):34-41. PubMed ID: 17139192
[TBL] [Abstract][Full Text] [Related]
18. Antistaphylococcal and biofilm inhibitory activities of acetyl-11-keto-β-boswellic acid from Boswellia serrata.
Raja AF; Ali F; Khan IA; Shawl AS; Arora DS; Shah BA; Taneja SC
BMC Microbiol; 2011 Mar; 11():54. PubMed ID: 21406118
[TBL] [Abstract][Full Text] [Related]
19. Boswellic acids stimulate arachidonic acid release and 12-lipoxygenase activity in human platelets independent of Ca2+ and differentially interact with platelet-type 12-lipoxygenase.
Poeckel D; Tausch L; Kather N; Jauch J; Werz O
Mol Pharmacol; 2006 Sep; 70(3):1071-8. PubMed ID: 16788089
[TBL] [Abstract][Full Text] [Related]
20. 3-O-acetyl-11-keto-boswellic acid decreases basal intracellular Ca2+ levels and inhibits agonist-induced Ca2+ mobilization and mitogen-activated protein kinase activation in human monocytic cells.
Poeckel D; Tausch L; George S; Jauch J; Werz O
J Pharmacol Exp Ther; 2006 Jan; 316(1):224-32. PubMed ID: 16174802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
